Proceedings of the 36th World Small Animal Veterinary Congress WSAVA
|
|
- Terence Jenkins
- 5 years ago
- Views:
Transcription
1 Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct , 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA
2 14(Fri) ~ 17(Mon) October 2011 ICC Jeju, Korea 2011 WSAVA FASAVA World Congress NA-D08(2) SX-A16 FELINE HYPERTENSION: RISKS, DIAGNOSIS AND MANAGEMENT Clarke Atkins, DVM, Diplomate, ACVIM (Internal Medicine & Cardiology) Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University, Raleigh, NC, USA Hypertension is the most important cardiovascular disease of the aged cat and the most important vascular disease in cats. Hence, its recognition and appropriate treatment is emerging as a critical component of small animal geriatric medicine. There are a host of target organs of hypertension. Our experience has shown that hypertensive cats have associated disease, in order of prevalence, of the eye, kidney, heart, and central nervous system.1 Etiology Hypertension in animals has largely been thought to be secondary to other disease (e.g. renal disease and endocrinopathies), as opposed to idiopathic (primary, essential), as is the case in most human hypertensives. This has recently been called into question. A report of 69 hypertensive cats, seen at North Carolina State University (NCSU) for ocular disease, revealed that at least 17%, and possibly as many as 50%, of cats had no identifiable cause for their systemic hypertension (primary or essential hypertension).1 Elliott and associates showed that approximately 20% of hypertensive cats, diagnosed in primary-care practice, were idiopathic2. Described and potential etiologies of secondary hypertension include chronic and acute renal disease, hyperthyroidism, hypothyroidism, hyperadrenocorticism, hyperaldosteronism, pheochromocytoma, diabetes mellitus, and obesity. Clearly chronic renal disease has the greatest association with hypertension and may often be causal. A recent report suggested approximately 29% of elderly cats with chronic renal disease were hypertensive.3 with a range of 4 studies from 19-65%.4 Pathogenesis The pathogenesis of hypertension is complex, not well understood, and beyond the scope of this work. However, several studies have indicated that the renin-angiotensin-aldosterone system (RAAS) is probably abnormally activated in many or, perhaps, most cats with systemic hypertension, particularly with concurrent renal disease, and certainly after therapy with such drugs as loop diuretics and vasodilators.5, WSAVA FASAVA World Congress Proceedings 627
3 Diagnosis of Systemic Hypertension Table - Adapated from ACVIM Hypertension Consensus STatement Draft 2004 Device Manufacturer Device Type Cardell Model 9401,2,3 Sharn Veterinary Inc. (800) Oscillometry Dinamap Model 8300 No longer available Oscillometry Jorgensen Model J5373 Memoprint, Memodiagnostic Parks Model 811-B Vet-Dop VetSpecs Model BP2,3 Jorgensen Labs (800) S & B medvet Parks Medical Electronics (800) Vmed Technology Inc (800) VetSpecs Medical Systems (800) Doppler ultrasonography Oscillometry Doppler ultrasonography Doppler ultrasonography Pressure plethysmography Guidelines of ACVIM Panel on Hypertension* Status SBP (mmhg) DBP (mmhg) Rx/Monitor Normal Pre-hypertensive Stage 1 hypertension** Stage 2 hypertension*** < >180 and or or or < >110 None None; Q3-6 mos ACE-I; Q1-3 mos ACE-I + Amlod; var. *ACVIM Consensus Panel on Hypertension **Kidneys at risk ***All target organs at risk Treatment; monitoring interval Diagnostic Methodology The Table above lists 6 currently available blood pressure monitors. They use one of 3 different methods, as can be seen in column 3. We currently use the Doppler method, which has the distinct disadvantage of not providing diastolic or mean blood pressures in most instances. We use the tail as our first appendage for blood pressure measurement, followed by the palmar surface of the front leg and finally dorsal surface of the rear leg. Cuff width is important and should approximate 30-40% of the circumference of the appendage used. Too small a cuff tends to overestimate and too large to underestimate true systemic blood pressure. The cuff position should approximate the level of the heart WSAVA FASAVA World Congress Proceedings
4 FELINE HYPERTENSION: RISKS, DIAGNOSIS AND MANAGEMENT Current recommendations are that blood pressure be measured in a quiet area prior to examining the patient, typically in the presence of the owner and after a 5-10 minute period of acclimation. The ACVIM Panel on Hypertension suggests discarding the first measurement, then obtaining a minimum of 3, preferably 5-7, consecutive measurements with less than 20% variability in systolic blood pressure. The conditions (including animal s disposition), cuff size, site and all measurements should be recorded in the medical record. Many clinicians require that hypertension be documented on more than one occasion before accepting the diagnosis. Below are published values for feline systemic blood pressures (systolic = SBP, mean = MBP, diastolic = DBP) obtained by various means. Arterial blood pressure (mmhg) values obtained from normal cats. (Adapted from ACVIM Consensus Statement Guidelines Draft 2004) Method # Cats SBP MBP DBP Method Cats SBP MBP DBP Intra-arterial (Direct) Brown et al, ± ± ± 9 Belew et al, ± ± ± 11 Oscillometry Bodey et al, ± ± ± 25 Mishina et al, ± ± ± 11 Doppler Method Klevans et al, ± 8 Kobayashi et al, ± 11 Sparkes et al, ± 19 Therapy Therapies for feline hypertension have varied and have not often been systematically evaluated. Therapies that have been employed and reported upon include diuretics (furosemide and spironolactone), angiotensinconverting enzyme inhibitors (ACE-I; captopril, enalapril, lisinopril, and benazepril), beta-blockers (propranolol and atenolol), and calcium channel blockers (diltiazem and amlodipine). Littman, retrospectively evaluated 24 cats with chronic renal failure (CRF), found that the most effective antihypertensive therapy was the combination of a beta-blocker and an ACE-I and that there was a poor response to furosemide.7 Jensen prospectively studied 12 similarly affected cats and found that the response to an ACE-I or beta-blocker alone was poor.8 Another retrospective study of 12 hypertensive cats with CRF and unresponsive to other therapy, showed amlodipine to lower blood pressure by >20% in 11.9 Snyder demonstrated blood pressure control in a randomized, blinded, placebo-controlled study of amlodipine in hypertensive cats, as well.10 Finally, the NCSU study retrospectively found amlodipine to lower blood pressure >20% in 30 of 32 hypertensive cats with 28 of 32 becoming normotensive.1 Diltiazem and beta-blockers alone or with ACE-I also lowered blood pressure in the majority of cats so treated. The literature and clinical experience would, nevertheless, lead one to appropriately conclude that amlodipine is the single best agent for the management of feline systemic hypertension. This said, beta-blockers have a specific role in slowing heart rate and blocking the cardiovascular 2011 WSAVA FASAVA World Congress Proceedings 629
5 effects of T3 in hyperthyroidism; ACE-I in combating drug-induced or spontaneous activation of the RAAS, for preserving renal function11,12, and for proven effects in lowering blood pressure13,14; spironolactone for its aldosterone-antagonistic effects15; and furosemide (possibly with nitroglycerin) for use in heart failure accompanying hypertension (See Table). Other therapeutic considerations include: whether there is activation of the RAAS (initially or iatrogenically), the role of the sympathetic nervous system, renal function and the effects of hypertension on renal function, salt intake, presence of heart failure (uncommon), and the presence of reversible causes of hypertension (e.g. hyperthyroidism, diabetes mellitus, adrenal tumors). Additionally, I try to limit the number of pills to 1 (or 2) daily to reduce strain on the human-animal bond. In deciding on a therapeutic approach, the author divides cats as follows: reversible cause - yes or no; with or without presumed RAAS activation (renal failure, heart failure, or treatment with vasodilators or loop diuretics); and by presence or absence of tachycardia (>200 bpm). The only common treatable cause of feline hypertension is hyperthyroidism, which is treated with methimazole, surgery, or 131I. In these cats, because of the effects of T3 on beta receptors, I employ a beta-blocker, such as atenolol ( mg PO daily), to reverse the cardiovascular effects of hyperthyroidism prior to or until more definitive therapy is efficacious. If unsuccessful, I add enalapril at 0.5 mg/kg/day PO. In all cases, I employ a moderately salt-restricted diet (one designed for kidney patients) to lessen total body sodium without worsening renal function or severely activating the RAAS. In the euthyroid, non-tachycardic cat with hypertension, the somewhat complex algorithm described below can be avoided by merely administering amlodipine and enalapril each day. I advise 1 tablet in the AM and 1 in the PM, if the owners schedule allows. If blood pressure control is not successful, see the material below. Algorithmic Approach to Hypertension RAAS not activated. If the RAAS is not thought to be activated (this may be an erroneous assumption) and tachycardia is not problematic, the approach is as follows: amlodipine (0.625 mg to 1.25 mg PO daily, or even higher if unresponsive) plus a moderately salt-restricted diet and enalapril. The ACE-I is used to counteract activation of the RAAS, produced by amlodipine.6 If unsuccessful, I first double the dosage of amlodipine, then sequentially add atenolol and finally diuretics (furosemide at mg daily or spironolactone at 1-2 mg/kg daily PO), if needed. It should be pointed out that, in cats unresponsive to amlodipine plus a second drug, owner compliance should be evaluated. If tachycardia is present (without RAAS activation), I begin with moderate salt restriction and atenolol. With atenolol monotherapy, even though heart rate typically falls, blood pressure control is often inadequate. In that circumstance, I, sequentially add amlodipine plus enalapril, then, if needed, double the amlodipine dosage, and finally add a diuretic. On the other hand, if heart rate control is not initially successful, the atenolol dose is first increased. If this does not bring the exam room heart rate to <160 or the at home heart rate to <140, I would substitute diltiazem (DilacorR at 30 mg PO bid) for amlodipine to better control heart rate and then follow the same sequence. RAAS abnormally activated. When conditions (heart failure, renal failure, or drug therapy) indicate the RAAS is inappropriately activated, I begin therapy with amlodipine, a moderately salt-restricted diet and enalapril. If a normotensive state does not result, I add, sequentially, atenolol and finally diuretics (furosemide WSAVA FASAVA World Congress Proceedings
6 FELINE HYPERTENSION: RISKS, DIAGNOSIS AND MANAGEMENT or spironolactone). Alternatively, if tachycardia is a concern, moderate salt restriction, atenolol, and enalapril would be used initially. If unsuccessful control of hypertension results, amlodipine would be added, and followed sequentially, as needed, by a doubling of the amlodipine dosage, and finally diuretic therapy if needed. If after initial therapy, heart rate control is inadequate, the atenolol dose is first increased. If this does not adequately control heart rate, I would substitute long-acting diltiazem (DilacorR at 30 mg PO bid) for amlodipine to better control heart rate and then follow the step-wise sequence mentioned above for blood pressure control, if needed. Heart failure secondary to hypertension is rare and will not be discussed except to say that diuretics will likely be necessary in such patients to control signs and that enalapril is indicated. Lastly, if renal failure or significant renal disease is present, the etiology should be sought (at least by urinalysis and culture) in the hopes of finding a reversible cause. Otherwise, treatment of renal disease is standard and beyond the scope of this manuscript. It is wise to consider the routes of excretion of the drugs being used in deciding dosage and dosing interval in the face of renal insufficiency. Lastly, hypotension may infrequently occur as a result of overexuberant anti-hypertensive therapy. This should be avoided as it may further compromise renal function. The prognosis, overall, for hypertension is guarded but not grave. Vision lost rarely returns but survival averages have ranged from months from the date of diagnosis.1,3 Cardiovascular Formulary for the Hypertensive Cat Drug Trade Name* Formulation(s)** Dosage Use Amlodipine Norvasc 1.25 mg tablets.625 PO qd-bid Antihypertensive Diltiazem Cardizem 30 mg tablets 7.5 mg PO tid Lusitrope, Vasodilator, Negative chronotrope Diltiazem - LA Dilacor XR 180, 240 mg caps. 30 mg PO bid same Cardizem CD 180, 240 mg caps. 45 mg PO qd same Enalapril Enacard (Vasotec) 1, 2.5, & 5 mg tablets.5 mg/kg PO qd ACE-I (CHF, Hypertension) Benazepril Lotensin (Foretkor) 5 & 10 mg tablets mg/kg PO qd-bid same Atenolol Tenormin 25 mg tablets mg PO qd Negative chronotrope, Antiarrhythmic, Lusitrope, Antihypertensive Nitroglycerin Nitrol, Nitro-Bid 2% ointment 1/8 ¼ inch topically tid for 24 hours Venodilator (CHF) LMW Heparin Fragmin 2500 U/.2 ml 100 U/kg SQ qd Anticoagulant Aspirin 81 mg mg q72h Anticoagulant 2011 WSAVA FASAVA World Congress Proceedings 631
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationPRESCRIPTION PATTERN OF ANTI HYPERTENSIVE DRUGS IN SHRI SATHYA SAI MEDICAL COLLEGE & RESEARCH INSTITUTE
Original Article PRESCRIPTION PATTERN OF ANTI HYPERTENSIVE DRUGS IN SHRI SATHYA SAI MEDICAL COLLEGE & RESEARCH INSTITUTE Annamalai Maduram 1, Harikrishna 2 INTRODUCTION High blood pressure, termed "hypertension,"
More informationJMSCR Vol 05 Issue 03 Page March 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i3.219 Comparative Study of Adverse Effect of
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationCats usually develop secondary hypertension with an
J Vet Intern Med 2015 Randomized Placebo-Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client-Owned Cats M. Huhtinen, G. Derre, H.J. Renoldi, M.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amodip 1.25 mg chewable tablets for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substance:
More informationFortekor 5 mg. Tablets for Dogs and Cats
Date: 9 April 2003 Page: 1 of 7 Carton, main panel PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Info pest Verified Fortekor 5 mg Tablets for Dogs and Cats Active Constituent:
More informationFrequently asked questions
Frequently asked questions At what stage of heart failure should Cardalis be used? Cardalis should be given as part of your standard heart failure therapy as soon as clinical signs (such as exercise intolerance,
More informationSynopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets
Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study
More informationU ing consequence^.^-^ Clinical signs referable to systemic
~~~ J Vet Intern Med 1998;12:157-162 Amlodipine: A Randomized, Blinded Clinical Trial in 9 Cats with Systemic Hypertension Patti S. Snyder The efficacy of amlodipine (AML) was tested in hypertensive cats
More informationStudy of the Side effects profile of different antihypertensive drugs among the Hypertensive patient
Study of the Side effects profile of different antihypertensive drugs among the Hypertensive patient Shrestha RK 1, Khan GM 1, Thapa P 1, Koju R 2 1 Department of Pharmacy, Kathmandu University 2 Department
More informationAssessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT,
Assessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT, Sylva LU SCHWAGER, Edward D STURROCK, Lubbe WIESNER, Brian
More informationJess Weidman, DVM, DACVIM- Cardiology CVCA Cardiac Care for Pets Dogwood Veterinary Emergency and Specialty
Jess Weidman, DVM, DACVIM- Cardiology CVCA Cardiac Care for Pets Dogwood Veterinary Emergency and Specialty Diagnostics Cardiac auscultation Chest Radiographs BNP Genetic testing Case Scenarios Pre-anesthesia
More informationPublic Assessment Report Scientific discussion. Perindopril tert-butylamine/amlodipine Stada (perindopril and amlodipine) SE/H/1500/01-04/DC
Public Assessment Report Scientific discussion Perindopril tert-butylamine/amlodipine Stada (perindopril and amlodipine) SE/H/1500/01-04/DC This module reflects the scientific discussion for the approval
More informationOriginal Article. Introduction. Korean Circulation Journal
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Valsartan 160 mg/amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 23 January 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 23 January 2008 ZANIDIP 10mg, film-coated tablets B/28 (CIP: 347 638.7) B/30 (CIP: 372 259.6) B/90 (CIP: 372 260.4)
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion SE/H/1397/01-05/DC Ramipril/Amlodipine Sandoz (ramipril/amlodipine) Applicant: Sandoz A/S This module reflects the scientific discussion for the approval
More informationC o n v e r s i b e n a z e p r. l i s i n o p r
C o n v e r s i b e n a z e p r t o l i s i n o p r Ace-inhibitor conversions. Common Medication Conversions (Equivalents) Ace Inhibitors : Drug Comparisons - Home Page. Hydrochlorothiazide; lisinopril
More informationTolerance and safety of enalapril
Br. J. clin. Pharmac. (1984), 18, 249S-253S Tolerance and safety of enalapril W. McFATE SMITH, R. 0. DAVIES, M. A. GABRIEL, D. M. KRAMSCH, F. MONCLOA, JANET E. RUSH & J. F. WALKER Merck Sharp & Dohme Research
More informationIrish Medicines Board
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (No. 2) REGULATIONS 2007 (S.I. No. 786 of 2007) VPA:10778/003/002 Case No: 7003735 The Irish Medicines Board in exercise of the powers
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cardalis 2.5 mg/20 mg tablets for dogs Cardalis 5 mg/40 mg tablets for dogs Cardalis 10 mg/80 mg tablets for dogs
More informationSUMMARY OF PRODUCT CHARACTERISTICS. KELAPRIL 2.5 mg, film coated tablets for dogs and cats [FR] KELAPRIL 2,5 film coated tablets for dogs and cats
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT KELAPRIL 2.5 mg, film coated tablets for dogs and cats [FR] KELAPRIL 2,5 film coated tablets for dogs and cats 2. QUALITATIVE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cardalis 2.5 mg/20 mg chewable tablets for dogs Cardalis 5 mg/40 mg chewable tablets for dogs Cardalis 10 mg/80
More informationConverting iv vasotec to po vasotec
Converting iv vasotec to po vasotec The Borg System is 100 % Retrievable Converting iv vasotec to po vasotec Conversion from IV to oral dosage form. If not concurrently receiving diuretics, initiate enalapril
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationEPAR type II variation for Metacam
23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents
More informationThe 4 th Generation calcium channel blocker C I L N I D I P I N E
T The 4 th Generation calcium channel blocker C I L N I D I P I N E = TOp DUal Action New Ca 2+ Channel Blocker Cilnidipine (IHS) - C 27 H 28 N 2 O 7 INDICATION Essential Hypertension DOSAGE & PACKAGE
More informationAMLODIPINE BESYLATE + OLMESARTAN MEDOXOMIL. Dihydropyridine Ca channel blocker [Dhp-CCB] + Angiotensin II receptor blockage [ARB]
AMLODIPINE BESYLATE + OLMESARTAN MEDOXOMIL Dihydropyridine Ca channel blocker [Dhp-CCB] + Angiotensin II receptor blockage [ARB] ESH/ESC HT MANAGEMENT GUIDELINE 2013 DIAGNOSIS TARGET BP TARGET BP CONTROL
More informationKeywords: Benazepril - Congestive heart failure - Dogs
Long-term tolerability of benazepril in dogs with congestive heart failure Jean-Louis Pouchelon 1 ; Jonathan King; Laure Martignoni; Valérie Chetboul; Béatrice Lugardon; Jean-François Rousselot; Jean-Philippe
More informationSurvival after diagnosis of hypertension in cats attending primary care practice in the United Kingdom
Received: 19 March 2017 Revised: 28 April 2018 Accepted: 24 July 2018 DOI: 10.1111/jvim.15307 STANDARD ARTICLE Survival after diagnosis of hypertension in cats attending primary care practice in the United
More informationPeriod of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)
Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency of Bayer's
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationMaximum antihypertensive effects are attained within 2 weeks after a change in dose. AZOR may be administered with other antihypertensive agents.
Page 4 FULL PRESCRIBING INFORMATION AZOR (amlodipine and olmesartan medoxomil) tablets USE IN PREGNANCY When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin
More informationWelcome! 10/26/2015 1
Welcome! Audio for this event is available via ReadyTalk Internet Streaming. No telephone line is required. Computer speakers or headphones are necessary to listen to streaming audio. Limited dial-in lines
More informationPresenting Complaint: Her owners were concerned because she seemed to be losing weight despite having a
AVTCP Case Report # 1 Case Log# 45 Hyperthyroidism with Concurrent Chronic Kidney Disease (CKD) Suzie Q. Technician, CVT Signalment: Maya is a 3 kg 15-year-old spayed female Domestic Shorthair. Presenting
More informationUnited Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE
United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Amodip 1.25
More information1 INDICATIONS AND USAGE. 1.1 Hypertension FULL PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMLODIPINE besylate tablets USP safely and effectively. See full prescribing information for AMLODIPINE
More information11/17/2015. Tox Tips: How to Easily Improve Your Management of Small Animal Poisoning Cases. November 17, The best pet insurance plan ever!
Tox Tips: How to Easily Improve Your Management of Small Animal Poisoning Cases November 17, 2015 Ahna Brutlag, DVM, MS, DABT, DABVT Associate Director of Veterinary Services Pet Poison Helpline abrutlag@petpoisonhelpline.com
More informationOverview. Clinical signs. Will you treat? Owner willing to treat? Surgical vs. Medical. Medical options
Part II (cushing s disease is hard to diagnose) Cushing s Disease Is Easy To Treat Why test? When to test? How to test? Will you treat? How to treat? Overview Thomas Schermerhorn, VMD, DACVIM(SAIM) Kansas
More informationDosage equivalent lisinopril amlodipine
Dosage equivalent 09/22/2017 Sons massage goes to far vol 2 09/23/2017 Integer game printable 09/25/2017 -Senior night invitation for parents -Games for anger management teenagers 09/26/2017 Minecraft
More informationReminder to Pharmacists. Issuance of Bulletin #58
Corporate and Provincial Program Support 300 Carlton, Winnipeg MB R3B 3M9 www.manitoba.ca/health Reminder to Pharmacists Issuance of Bulletin #58 Bulletin #58, effective April 29, 2008, completes the initial
More informationNew Zealand Data Sheet. Apo-Amlodipine
New Zealand Data Sheet Apo-Amlodipine Presentation APO-AMLODIPINE 2.5mg are white to off-white, round unscored tablets, engraved APO on one side and AML over 2.5 on the other side. Each tablet typically
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 16 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Pimovita 10 mg chewable tablets for dogs Pimovita vet.10 mg chewable tablets for
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 10 Mar 2019 06:52:14 GMT) CTRI Number Last Modified On 29/07/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More information1.1. ACE-inhibitors and flushing
1.1. ACE-inhibitors and Introduction Angiotensin-converting enzyme (ACE) inhibitors are widely used for the treatment of and heart failure. The following ACE-inhibitors are registered in the Netherlands:
More informationCHEMMART AMLODIPINE 2.5 mg, 5 mg, 10 mg TABLETS
CHEMMART AMLODIPINE 2.5 mg, 5 mg, 10 mg TABLETS Product Information Australia NAME OF THE MEDICINE Amlodipine besylate. DESCRIPTION Amlodipine besylate is a dihydropyridine derivative. Chemical Name: 3-ethyl
More informationSubmission for Reclassification
Submission for Reclassification Fucithalmic (Fusidic Acid 1% Eye Drops) From Prescription Medicine to Restricted Medicine (Pharmacist Only Medicine) CSL Biotherapies (NZ) Limited 666 Great South Road Penrose
More informationIntroduction to Canine and Feline Dispensing
SCSHP 2014 Annual Meeting Introduction to Canine and Feline Dispensing Clay Sprouse, BA, CPhT Piedmont Technical College A house is not a home without a pet. Unknown Animals are such agreeable friends
More informationDRUG INTERACTIONS
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT FORTEKOR PLUS 1.25 mg/2.5 mg tablets for dogs FORTEKOR PLUS 5 mg/10 mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE
More informationPATIENT INFORMATION LEAFLET ACCEL-AMLODIPINE. Amlodipine Tablets 5 mg and 10 mg amlodipine (as amlodipine besylate) Antihypertensive-Antianginal Agent
PATIENT INFORMATION LEAFLET Pr ACCEL-AMLODIPINE Amlodipine Tablets 5 mg and 10 mg amlodipine (as amlodipine besylate) Antihypertensive-Antianginal Agent ACTION AND CLINICAL PHARMACOLOGY ACCEL-AMLODIPINE
More informationISMP Canada HYDROmorphone Knowledge Assessment Survey
ISMP Canada HYDROmorphone Knowledge Assessment Survey Knowledge Assessment Questions 1. In an equipotent dose, HYDROmorphone is more potent than morphine. True False Unsure 2. HYDROmorphone can be given
More informationHeartworm Disease in Dogs
Customer Name, Street Address, City, State, Zip code Phone number, Alt. phone number, Fax number, e-mail address, web site Heartworm Disease in Dogs Basics OVERVIEW Disease caused by infestation with heartworms
More informationPBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak
PBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak Dwaipayan Mukherjee, Ph.D. Jiuhong Zha, Ph.D. Rajeev Menon, Ph.D. Mohamad Shebley, Ph.D. Clinical
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT NOSEDORM 5 mg/ml Solution for injection for dogs and cats [DE, ES, FR, PT] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationLotrel (amlodipine besylate and benazepril hydrochloride) Combination Capsules
T2004-83 Lotrel (amlodipine besylate and benazepril hydrochloride) Combination Capsules 2.5 mg/10 mg 5 mg/10 mg 5 mg/20 mg 10 mg/20 mg Rx only Prescribing Information USE IN PREGNANCY When used in pregnancy
More informationPage 1 of 21. Tablets: 2.5 mg, 5 mg, and 10 mg (3)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE
More informationNEW ZEALAND DATA SHEET
NEW ZEALAND DATA SHEET 1. PRODUCT NAME NORVASC 5 mg and 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 mg coated tablet contains amlodipine besilate equivalent to 5 mg amlodipine. Each
More informationAntihypertensive efficacy of amlodipine in children with chronic kidney diseases
(2001) 15, 387 391 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Antihypertensive efficacy of amlodipine in children with chronic kidney diseases
More informationSenior Pet Care and Early Disease Detection
Senior Pet Care and Early Disease Detection Thanks to advances in veterinary medicine, pets are living longer than ever before. However, with this increased lifespan comes an increase in the types of ailments
More informationProceedings Saturday, October 14 Atlanta Marriott Century Center
Proceedings Saturday, October 14 Atlanta Marriott Century Center Feline Cardiomyopathy Kathryn M. Meurs, DVM, PhD Kate_meurs@ncsu.edu Diplomate ACVIM (Cardiology) There are many forms of feline cardiomyopathy
More informationCompanion Animal TREATMENT: HYPERADRENOCORTICISM (CUSHING S SYNDROME) IN DOGS
Edward C. Feldman, DVM Diplomate ACVIM (SAIM), Professor Emeritus, Small Animal Internal Medicine University of California Davis, California 95616 8737 ecfeldman@ucdavis.edu TREATMENT: HYPERADRENOCORTICISM
More information1. Ask. Top 5 Steps to Practice Evidence-Based Veterinary Medicine TOP 5 STEPS TO PRACTICE EVIDENCE- BASED VETERINARY MEDICINE
TOP 5 h DIAGNOSTICS h PEER REVIEWED Top 5 Steps to Practice Evidence-Based Veterinary Medicine Sebastian Arlt, Dr.med.vet, DECAR Free University of Berlin Berlin, Germany Veterinarians in all disciplines
More informationSAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY. Aileen Milne PhD, Manager, Safety Pharmacology
SAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY Aileen Milne PhD, Manager, Safety Pharmacology SAFETY PHARMACOLOGY SERVICES OVERVIEW Full Range of S7A and S7B studies herg assay Respiratory function plethysmography(rat/mouse)
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT GALLIPRANT 20 mg tablets for dogs GALLIPRANT 60 mg tablets for dogs GALLIPRANT 100 mg tablets for dogs 2. QUALITATIVE
More informationNorvasc 5 & 10mg tablets
Norvasc 5 & 10mg tablets 1. Name of the medicinal product Norvasc 5& 10 mg Tablets 2. Qualitative and quantitative composition Each tablet contains amlodipine besilate equivalent to 5 and 10mg amlodipine.
More informationBOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin
BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin 2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES Each ml contains: Tilmicosin 300 mg;
More informationLUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification
LUPIN LIMITED SAFETY DATA SHEET Section 1: Identification Section 1, Identification Material Manufacturer Distributor Amlodipine Besylate and Benazepril Hydrochloride Capsules 2.5 mg/10 mg, 5 mg/10 mg,
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Medicine of Cats Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2016 Medicine of Cats Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal Answer
More informationAUSTRALIAN PRODUCT INFORMATION AMLO (AMLODIPINE BESILATE) UNCOATED TABLETS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
AUSTRALIAN PRODUCT INFORMATION AMLO (AMLODIPINE BESILATE) UNCOATED TABLETS 1 NAME OF THE MEDICINE Amlodipine besilate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION AMLO contains the active ingredient Amlodipine
More informationOther Available Assistance Programs Angiotensin Receptor Blocker (ARB)
BENICAR 20 MG TABS (olmesartan) Angiotensin Receptor Blocker (ARB) Daiichi Sankyo Open Care Program These are the best alternatives for Benicar in terms of similarity of medication: EDARBI MG TABS (azilsartan)
More information2017 Medicare Part D Step Therapy Requirements. Effective: November 01, 2017
2017 Medicare Part D Step Therapy Requirements Effective: November 01, 2017 Formulary ID 17192, Version 19 Last Updated: 10/24/2017 BISPHOSPHONATE THERAPY FOSAMAX PLUS D 70 MG-2,800 UNIT FOSAMAX PLUS D
More informationSANDOZ AMLODIPINE PRODUCT MONOGRAPH. Amlodipine Besylate. Tablets 2.5 mg, 5 mg and 10 mg. Antihypertensive-Antianginal Agent
PRODUCT MONOGRAPH Pr SANDOZ AMLODIPINE Amlodipine Besylate Tablets 2.5 mg, 5 mg and 10 mg Antihypertensive-Antianginal Agent Sandoz Canada Inc. Date of Revision: 145 Jules Léger December 1, 2017 Boucherville,
More informationProceedings of the Congreso Ecuatoriano de Especialidades Veterinarias CEEV Nov , 2011 Quito, Ecuador
Close this window to return to IVIS www.ivis.org Proceedings of the Congreso Ecuatoriano de Especialidades Veterinarias CEEV 2011 Nov. 15-17, 2011 Quito, Ecuador Reprinted in IVIS with the permission of
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationPrescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children
Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Antimicrobials for Common Illnesses When treating common illnesses such as ear infections and strep throat,
More informationCOMPLICATED CUSHING S CASES AND CONCURRENT CONDITIONS
Vet Times The website for the veterinary profession https://www.vettimes.co.uk COMPLICATED CUSHING S CASES AND CONCURRENT CONDITIONS Author : Gerard Mclauchlan, Ian Ramsey Categories : Vets Date : August
More informationmelatonin amlodipine generic for amlodipine benazepril amlodipine angioedema amlodipine feline amlodipine 5 mg description
Follow all directions on your computer even when amlodipine for sale you buy Ambien. Call your doctor or dial 911 immediately. Ativan can cause tolerance, physical dependence, addiction and withdrawal
More informationPRODUCT MONOGRAPH. amlodipine besylate. Tablets 2.5, 5 and 10 mg. Antihypertensive-Antianginal Agent
PRODUCT MONOGRAPH Pr NORVASC amlodipine besylate Tablets 2.5, 5 and 10 mg Antihypertensive-Antianginal Agent PFIZER CANADA INC. 17 300 Trans-Canada Highway Kirkland, Quebec H9J 2M5 Date of Revision: September
More informationWithdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.
A. LABELLING PARTICULARS TO APPEAR ON THE OUTER PACKAGE AND THE IMMEDIATE PACKAGE CARTON BOX AND LABELS OF 100 ml and 250 ml 1. NAME OF THE VETERINARY MEDICINAL PRODUCT TILKOMAY 300 mg/ml + 90 mg/ml solution
More informationBenazepril equivalent dose of lisinopril
Benazepril equivalent dose of lisinopril 11/25/2017 Hcpcs code j7613 not covered by medicare 11/26/2017 Pay att uverse bill over phone 11/28/2017 -Pill h5 325 -Shelby scott wbz reporter dementia 11/29/2017
More informationPRODUCT MONOGRAPH SANDOZ AMLODIPINE. Amlodipine Besylate. Tablets 2.5 mg, 5 mg and 10 mg. Antihypertensive-Antianginal Agent
PRODUCT MONOGRAPH Pr SANDOZ AMLODIPINE Amlodipine Besylate Tablets 2.5 mg, 5 mg and 10 mg Antihypertensive-Antianginal Agent Sandoz Canada Inc. Date of Revision: 145 Jules Léger September 25, 2015 Boucherville,
More informationNursing intervention for amlodipine
Nursing intervention for amlodipine Amlodipine is a calcium channel blocking agent that selectively blocks calcium ion reflux across cell membranes of cardiac and vascular smooth muscle without. PHYSICAL
More informationPRODUCT MONOGRAPH. Pr AMLODIPINE. Amlodipine Besylate Tablets, House Standard. 5 mg and 10 mg. Amlodipine (as amlodipine besylate)
PRODUCT MONOGRAPH Pr AMLODIPINE Amlodipine Besylate Tablets, House Standard 5 mg and 10 mg Amlodipine (as amlodipine besylate) Antihypertensive-Antianginal Agent JAMP Pharma Corporation Date of Preparation:
More informationPathogenesis and treatment of feline lower urinary tract disease
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Pathogenesis and treatment of feline lower urinary tract disease Author : Sarah Caney Categories : RVNs Date : May 1, 2011
More informationProceedings of the 13th International Congress of the World Equine Veterinary Association WEVA
www.ivis.org Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA October 3-5, 2013 Budapest, Hungary Reprinted in IVIS with the Permission of the WEVA Organizers
More informationJust where it s needed.
Relief. Just where it s needed. Tissue-selective 7,8 Strong safety profile 5,6,10,11 For dogs and cats Onsior is available in a range of convenient and easy-to-dose formulations. Injectable solution for
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Amlodipine Bluefish 5 mg tablets Amlodipine Bluefish 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationA Staged Approach to Diagnosis and Management of Chronic Kidney Disease in Cats
A Staged Approach to Diagnosis and Management of Chronic Kidney Disease in Cats A Roundtable Discussion Sponsored by Purina Pro Plan Veterinary Diets DIAGNOSIS OF CHRONIC KIDNEY DISEASE Dr. Laflamme: Chronic
More informationAMLODIPINE BESILATE / ATORVASTATIN CALCIUM
1. THERAPEUTIC CATEGORY Calcium Channel Blocker Lipid Regulating Agent AMLODIPINE BESILATE / ATORVASTATIN CALCIUM NORVASC PROTECT 2. FORMULATION Amlodipine besilate/atorvastatin calcium (Norvasc Protect)
More informationAPO-AMLODIPINE/ATORVASTATIN 5/10, 5/20, 5/40, 5/80, 10/10, 10/20, 10/40 & 10/80 TABLETS
APO-AMLODIPINE/ATORVASTATIN 5/10, 5/20, 5/40, 5/80, 10/10, 10/20, 10/40 & 10/80 TABLETS NAME OF THE MEDICINE Amlodipine (as besylate) and Atorvastatin (as calcium propylene glycol solvate) Active Ingredient
More informationNAME OF THE MEDICINE. PRODUCT INFORMATION Cadivast Amlodipine (as besilate) and atorvastatin (as calcium trihydrate) tablets
PRODUCT INFORMATION Cadivast Amlodipine (as besilate) and atorvastatin (as calcium trihydrate) tablets NAME OF THE MEDICINE The active ingredients in Cadivast are amlodipine besilate and atorvastatin calcium
More informationNUMBER: R&C-ARF-10.0
1. PURPOSE PAGE 1 OF 6 This policy describes the procedures for keeping and maintaining animal medical records. This procedure is approved by the Creighton University Institutional Animal Care and Use
More informationPRODUCT MONOGRAPH. Amlodipine Besylate tablets. 2.5 mg, 5 mg & 10 mg (amlodipine as amlodipine besylate) Antihypertensive-Antianginal Agent
PRODUCT MONOGRAPH Pr AMLODIPINE Amlodipine Besylate tablets 2.5 mg, 5 mg & 10 mg (amlodipine as amlodipine besylate) Antihypertensive-Antianginal Agent Sivem Pharmaceuticals ULC 4705 Dobrin Street St.
More informationMetacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.
Metacam The Only NSAID Approved for Cats in the US John G. Pantalo, VMD Professional Services Veterinarian Think easy. Think cat. Think METACAM. Today s Agenda New pain management guidelines for cats Only
More informationPRODUCT MONOGRAPH. amlodipine besylate. Tablets 2.5, 5 and 10 mg. Antihypertensive-Antianginal Agent
PRODUCT MONOGRAPH Pr GD -AMLODIPINE amlodipine besylate Tablets 2.5, 5 and 10 mg Antihypertensive-Antianginal Agent GenMed, a division of Pfizer Canada Inc. 17 300 Trans-Canada Highway Kirkland, Quebec
More informationNon-steroidal anti-inflammatory drugs (NSAIDs) are used widely to relieve pain, with or without
May 2013 Contents About NSAIDs What about COXselectivity? How effective are NSAIDs? Adverse effects of NSAIDs How frequent are the adverse effects of NSAIDs? General prescribing guidelines for NSAIDs What
More information